Chemoinformaics analysis of D-N-METHYL-PSEUDOEPHEDRINE
| Molecular Weight | 179.263 | nRot | 3 |
| Heavy Atom Molecular Weight | 162.127 | nRig | 6 |
| Exact Molecular Weight | 179.131 | nRing | 1 |
| Solubility: LogS | -0.866 | nHRing | 0 |
| Solubility: LogP | 1.49 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 31.6075 |
| nHD | 1 | BPOL | 18.7645 |
| QED | 0.763 |
| Synth | 2.622 |
| Natural Product Likeliness | 0.361 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.009 |
| HIA | 0.01 |
| CACO-2 | -5.044 |
| MDCK | 0.0000172 |
| BBB | 0.743 |
| PPB | 0.150714 |
| VDSS | 3.849 |
| FU | 0.764602 |
| CYP1A2-inh | 0.098 |
| CYP1A2-sub | 0.52 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.97 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.219 |
| CYP2d6-inh | 0.817 |
| CYP2d6-sub | 0.909 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.76 |
| CL | 13.145 |
| T12 | 0.469 |
| hERG | 0.053 |
| Ames | 0.008 |
| ROA | 0.842 |
| SkinSen | 0.071 |
| Carcinogencity | 0.082 |
| EI | 0.037 |
| Respiratory | 0.928 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.733491 |